DE3650641D1 - Peptidfragment des menschlichen Villins und Antikörper dagegen - Google Patents

Peptidfragment des menschlichen Villins und Antikörper dagegen

Info

Publication number
DE3650641D1
DE3650641D1 DE3650641T DE3650641T DE3650641D1 DE 3650641 D1 DE3650641 D1 DE 3650641D1 DE 3650641 T DE3650641 T DE 3650641T DE 3650641 T DE3650641 T DE 3650641T DE 3650641 D1 DE3650641 D1 DE 3650641D1
Authority
DE
Germany
Prior art keywords
human
peptide fragment
villins
antibodies against
villin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3650641T
Other languages
English (en)
Other versions
DE3650641T2 (de
Inventor
Daniel Louvard
Brigitte Dudouet
Sylvie Robine
Monique Arpin
Eric Pringault
Alphonse Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8506707A external-priority patent/FR2581456B1/fr
Priority claimed from FR8516820A external-priority patent/FR2589882B2/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE3650641D1 publication Critical patent/DE3650641D1/de
Application granted granted Critical
Publication of DE3650641T2 publication Critical patent/DE3650641T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4735—Villin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE3650641T 1985-05-02 1986-04-30 Peptidfragment des menschlichen Villins und Antikörper dagegen Expired - Fee Related DE3650641T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8506707A FR2581456B1 (fr) 1985-05-02 1985-05-02 Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
FR8516820A FR2589882B2 (fr) 1985-11-13 1985-11-13 Moyens pour le diagnostic in vitro de cellules malignes originaires du tube digestif

Publications (2)

Publication Number Publication Date
DE3650641D1 true DE3650641D1 (de) 1997-09-04
DE3650641T2 DE3650641T2 (de) 1998-03-05

Family

ID=26224488

Family Applications (2)

Application Number Title Priority Date Filing Date
DE86400957T Expired - Fee Related DE3689084T2 (de) 1985-05-02 1986-04-30 Verfahren zur in vitro-Diagnose von bösartigen Zellen aus dem Verdauungstrakt.
DE3650641T Expired - Fee Related DE3650641T2 (de) 1985-05-02 1986-04-30 Peptidfragment des menschlichen Villins und Antikörper dagegen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE86400957T Expired - Fee Related DE3689084T2 (de) 1985-05-02 1986-04-30 Verfahren zur in vitro-Diagnose von bösartigen Zellen aus dem Verdauungstrakt.

Country Status (5)

Country Link
EP (2) EP0502553B1 (de)
JP (4) JP2698326B2 (de)
AT (1) ATE156136T1 (de)
DE (2) DE3689084T2 (de)
WO (1) WO1986006494A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635389A (en) * 1985-05-02 1997-06-03 Institut Pasteur Antibodies which recognize and bind human villin
IL89102A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Vectors,compounds and methods for expression of a human adenocarcinoma antigen
DE3805447A1 (de) * 1988-02-22 1989-08-31 Drenckhahn Detlef Verfahren und mittel zur bestimmung von nierenschaeden
FR2638464B1 (fr) * 1988-10-28 1992-01-03 Pasteur Institut Fragments d'acide nucleique specifiques du gene de la villine humaine, leur utilisation aux fins de diagnostic
FR2645877B1 (fr) * 1989-04-12 1991-07-05 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un, ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum au niveau du stade sporozoite et dans les hepatocytes
US5830729A (en) 1996-04-18 1998-11-03 Institut Pasteur I Sce I-induced gene replacement and gene conversion in embryonic stem cells
JP7158642B2 (ja) * 2018-01-16 2022-10-24 国立大学法人山梨大学 質量分析装置及び質量分析システム

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon

Also Published As

Publication number Publication date
EP0206849A2 (de) 1986-12-30
EP0502553B1 (de) 1997-07-30
JPH11123091A (ja) 1999-05-11
EP0502553A2 (de) 1992-09-09
EP0206849A3 (en) 1987-08-05
DE3689084T2 (de) 1994-04-28
JPH1066574A (ja) 1998-03-10
EP0206849B1 (de) 1993-09-29
JPH08208699A (ja) 1996-08-13
JP2698326B2 (ja) 1998-01-19
WO1986006494A3 (fr) 1987-03-26
DE3689084D1 (de) 1993-11-04
ATE156136T1 (de) 1997-08-15
JP2698337B2 (ja) 1998-01-19
DE3650641T2 (de) 1998-03-05
JPH07188300A (ja) 1995-07-25
WO1986006494A2 (fr) 1986-11-06
EP0502553A3 (en) 1994-05-25

Similar Documents

Publication Publication Date Title
DE69333802T8 (de) Äusseres membranprotein von haemophilus
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
BR9500732A (pt) Peptídio imunologicamente ativo,fragmento de DNA isolado,kit de teste e aplicação
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
ATE63138T1 (de) Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren.
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
DE69334350D1 (de) P- Selectin Ligandenprotein
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
NO940299L (no) Peptid med organbeskyttende aktivitet
DE3650641T2 (de) Peptidfragment des menschlichen Villins und Antikörper dagegen
SE8505920D0 (sv) New protein and its use
DE69012901D1 (de) Hämoregulierende Peptide.
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
EP0723016A3 (de) Leukocyten-aktivierender Faktor
NO921219D0 (no) Somatostatin reseptor
EP0272894A3 (de) Rekombinantes menschliches Lymphotoxin
FR2744122B1 (fr) Nouveaux agents edulcorants derivant de l'acide n-(4-cyanophenylcarbamoyl ou 2-cyanopyrid-5-ylcarbamoyl)-l- aspartique alpha-benzenamide 3-monosubstitue
KR880006359A (ko) 사람의 tiits를 제조하기 위한 중간물질로서의 균일한 양 tiits 및 이의 용도
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
TH22943A (th) รีคอมบิแนนท์โปรตีนที่กำหนดเป็น dev-1 ที่มีประโยชน์สำหรับตรวจหา hiv ลำดับดีเอนเอที่ประมวลรหัสของโปรตีนและการวิเคราะห์ทางอิมมูนโดยใช้โปรตีนนี้

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee